Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-23-000028
Filing Date
2023-08-03
Accepted
2023-08-03 16:46:59
Documents
113
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20230630.htm   iXBRL 10-Q 2818355
2 EX-31.1 exhibit311q22023.htm EX-31.1 10086
3 EX-31.2 exhibit312q22023.htm EX-31.2 10116
4 EX-32.1 exhibit321q22023.htm EX-32.1 6569
5 EX-32.2 exhibit322q22023.htm EX-32.2 6621
  Complete submission text file 0000885590-23-000028.txt   13778712

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20230630.xsd EX-101.SCH 100298
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20230630_cal.xml EX-101.CAL 95008
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20230630_def.xml EX-101.DEF 597359
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20230630_lab.xml EX-101.LAB 1006410
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20230630_pre.xml EX-101.PRE 772095
107 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20230630_htm.xml XML 2420556
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 231140879
SIC: 2834 Pharmaceutical Preparations